180 Life Sciences Corp
NASDAQ:ATNF

Watchlist Manager
180 Life Sciences Corp Logo
180 Life Sciences Corp
NASDAQ:ATNF
Watchlist
Price: 16.8 USD 0.6%
Market Cap: 2.6B USD

Net Margin
180 Life Sciences Corp

0%
Current
0%
Average
-6.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-17.2m
/
Revenue
0

Net Margin Across Competitors

No Stocks Found

180 Life Sciences Corp
Glance View

Market Cap
2.6B USD
Industry
Biotechnology

180 Life Sciences Corp. develops pharmaceuticals for chronic pain and inflammatory diseases. The company is headquartered in Menlo Park, California and currently employs 7 full-time employees. The company went IPO on 2017-06-07. The firm is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by research and combination therapy. The Company’s programs developing novel drugs for treating distinct inflammatory diseases. The firm has three product development platforms Anti-TNF platform, SCAs platform and α7nAChR platform. The Anti-TNF platform is focused on the fibrosis and anti-tumor necrosis factor (anti-TNF). The SCAs platform is focused on the drugs that are synthetic cannabidiol (CBD) or cannabigerol (CBG) analogues (SCAs). The α7nAChR platform, which is focused on the alpha 7 nicotinic acetylcholine receptor (α7nAChR). The firm is conducting clinical trials only for certain indications under the anti-TNF platform. The firm is also undertaking preclinical research and development activities for the SCA and the α7nAChR platforms.

ATNF Intrinsic Value
Not Available
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-17.2m
/
Revenue
0
What is the Net Margin of 180 Life Sciences Corp?

Based on 180 Life Sciences Corp's most recent financial statements, the company has Net Margin of 0%.

Back to Top